𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals

✍ Scribed by Domenico Russo Alesi; Francesca Ajello; Giuseppina Lupo; Francesco Vitale; Mario Portera; Filippo Spadaro; Prof. Nino Romano


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
548 KB
Volume
27
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


An assay based on inhibition of cytopathic effect of human immunodeficiency virus (HIV) strains in Molt 4 cells was developed to quantitate neutralizing antibodies (NA) in sera of HIV-infected individuals. The assay was specific and gave results comparable to those obtained by the inhibition of immunofluorescence (IFI) and reverse transcriptase (RT) activity. Attempts were made to correlate the presence and the antibody titres with the clinical status of HIV-infected individuals classified according to Walter Reed staging classification scheme. NA titres correlated inversely with the stage of HIV infection: Compared with acquired immunodeficiency syndrome (AIDS) patients, HIV-infected subjects at stage WR1 had significantly higher NA titres. Moreover, a decrease in NA titre in relation to clinical deterioration was noted in sequential sera of eight of 11 AIDS patients, retrospectively examined, for NA. The symptomless subjects showed either the same level of NA or a trend towards an increasing antibody titre with time. Different isolates of HIV strains showed a variability in the extent of sensitivity to neutralization by sera obtained from different HIV-infected individuals.


πŸ“œ SIMILAR VOLUMES


Accentuated antibody response to paramyx
✍ Jan KΓΆvamees; Hooshmand Sheshberadaran; Francesca Chiodi; Stefan Schwartz; Claes πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 550 KB

Sera from 31 human immunodeficiency virus (HIV)-infected patients, representing different clinical stages of HIV infection, were assayed for antibodies against measles and mumps viruses by various serological tests and compared to 23 healthy controls. Sera from four patients (two primary, one asympt

Prevalence of antiphospholipid and antip
✍ IvΓ‘n Palomo; Marcelo AlarcΓ³n; Cecilia Sepulveda; Jaime Pereira; Ricardo Espinola πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract Antiphospholipid (aPL) and antiplatelet (aPlt) antibodies, found in patients with autoimmune diseases, are also detected in infectious diseases. The purpose of this study was to examine the prevalence of these antibodies in HIV patients and to evaluate an association of these antibodies

Hepatitis C virus antibody prevalence am
✍ Dr. Claudius Micha NΓΌbling; Gudrun Von Wangenheim; Schlomo Staszewski; Johannes πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 568 KB

## Abstract Sera of 383 human immunodeficiency virus (HIV)‐l‐infected individuals from Frankfurt (Main)/Germany were assayed by two hepatitis C virus (HCV) screening tests (Abbott second generation, Ortho second generation). This population showed a prevalence for reactivity with both tests of 20.8

The problem of human immunodeficiency vi
✍ Robert H. Rubin; Nina E. Tolkoff-Rubin πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 852 KB

The problem of human immunodeficiency virus (HIV) infection and that of the acquired immunodeficiency syndrome (AIDS) are becoming increasingly important in clinical transplantation. The epidemiologic characteristics of this infection are important factors in determining the impact of this infection